Correlation Between Kezar Life and NeuroSense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kezar Life and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on Kezar Life and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and NeuroSense Therapeutics.
Diversification Opportunities for Kezar Life and NeuroSense Therapeutics
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kezar and NeuroSense is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of Kezar Life i.e., Kezar Life and NeuroSense Therapeutics go up and down completely randomly.
Pair Corralation between Kezar Life and NeuroSense Therapeutics
Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the NeuroSense Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Kezar Life Sciences is 23.8 times less risky than NeuroSense Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The NeuroSense Therapeutics Ltd is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 30.00 in NeuroSense Therapeutics Ltd on August 31, 2024 and sell it today you would lose (6.00) from holding NeuroSense Therapeutics Ltd or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 70.32% |
| Values | Daily Returns |
Kezar Life Sciences vs. NeuroSense Therapeutics Ltd
Performance |
| Timeline |
| Kezar Life Sciences |
| NeuroSense Therapeutics |
Kezar Life and NeuroSense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kezar Life and NeuroSense Therapeutics
The main advantage of trading using opposite Kezar Life and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.| Kezar Life vs. Cue Biopharma | Kezar Life vs. Eliem Therapeutics | Kezar Life vs. Inhibrx | Kezar Life vs. Molecular Partners AG |
| NeuroSense Therapeutics vs. Neurosense Therapeutics | NeuroSense Therapeutics vs. Pasithea Therapeutics Corp | NeuroSense Therapeutics vs. GeoVax Labs | NeuroSense Therapeutics vs. NLS Pharmaceutics AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |